Vaccitech Ltd. announced the appointment of two new independent directors to its Board of Directors. Dr. Anne Phillips and Karen A. Dawes joined the Board on 17 February 2021. Their appointments add strong independent perspectives on drug development and commercialization to Vaccitech’s Board. Dr. Phillips has extensive biopharmaceutical product development experience. She currently serves as Senior Vice President Clinical, Medical & Regulatory Affairs at Novo Nordisk, where she has overseen more than a dozen FDA drug approvals. More recently, Ms. Dawes has led her own successful consultancy company working with emerging companies on corporate strategy and commercial development.